← All CategoriesAPI Portfolio

Anti Cancer APIs

Cytotoxic agents, targeted kinase inhibitors, antimetabolites, and hormone-pathway APIs for oncology and oncology-adjacent indications. Supplied in pharmaceutical grade for IV, oral, and topical formulation manufacturing.

Regulatory ReadyCOA, DMF & CEP supportUSP / EP / BPPharmacopoeial grade APIsFull TraceabilityBatch-to-batch documentation
Request Anti Cancer API Catalogue
All Anti Cancer APIs

13 APIs available

Page 1 of 1
CAS 51-21-8 Product Code AC-001 WHO-GMP

5-Fluorouracil

Pyrimidine antimetabolite in USP/EP/BP/IP grade for IV injectable and topical formulation manufacturing. Sourced for colorectal, breast, and head & neck cancer treatment protocols.

USP EP BP IP Injection Topical
Anti Cancer API

5-Fluorouracil

CAS
51-21-8
Product Code
AC-001
Category
Anti Cancer
Specification
USP / EP / BP / IP
Quality
WHO-GMP
Applications
Injection · Topical

Full description

Pyrimidine antimetabolite in USP/EP/BP/IP grade for IV injectable and topical formulation manufacturing. Sourced for colorectal, breast, and head & neck cancer treatment protocols.

CAS 154361-50-9 Product Code AC-002 WHO-GMP

Capecitabine

Oral fluoropyrimidine prodrug in USP/EP grade for tablet formulation manufacturing, converted to 5-FU in tumour tissue. Sourced for metastatic breast and colorectal cancer product lines.

USP EP Oral
Anti Cancer API

Capecitabine

CAS
154361-50-9
Product Code
AC-002
Category
Anti Cancer
Specification
USP / EP
Quality
WHO-GMP
Applications
Oral

Full description

Oral fluoropyrimidine prodrug in USP/EP grade for tablet formulation manufacturing, converted to 5-FU in tumour tissue. Sourced for metastatic breast and colorectal cancer product lines.

CAS 114977-28-5 Product Code AC-004 WHO-GMP

Docetaxel

Semi-synthetic taxane in pharmaceutical grade (anhydrous and trihydrate forms available) for IV infusion formulation manufacturing. Sourced for breast, lung, prostate, and ovarian cancer treatment protocols.

Injection
Anti Cancer API

Docetaxel

CAS
114977-28-5
Product Code
AC-004
Category
Anti Cancer
Quality
WHO-GMP
Applications
Injection

Full description

Semi-synthetic taxane in pharmaceutical grade (anhydrous and trihydrate forms available) for IV infusion formulation manufacturing. Sourced for breast, lung, prostate, and ovarian cancer treatment protocols.

CAS 164656-23-9 Product Code AC-003 WHO-GMP

Dutasteride

Dual 5-alpha reductase inhibitor in pharmaceutical grade for soft gelatin capsule manufacturing. Primarily sourced for benign prostatic hyperplasia formulation lines, with research use in prostate cancer chemoprevention.

Oral
Anti Cancer API

Dutasteride

CAS
164656-23-9
Product Code
AC-003
Category
Anti Cancer
Quality
WHO-GMP
Applications
Oral

Full description

Dual 5-alpha reductase inhibitor in pharmaceutical grade for soft gelatin capsule manufacturing. Primarily sourced for benign prostatic hyperplasia formulation lines, with research use in prostate cancer chemoprevention.

CAS 33419-42-0 Product Code AC-013 WHO-GMP

Etoposide

Topoisomerase II inhibitor in pharmaceutical grade (≥95% HPLC purity) for capsule and IV solution formulation manufacturing. Sourced for testicular cancer, small-cell lung cancer, and lymphoma treatment protocols.

Oral Injection
Anti Cancer API

Etoposide

CAS
33419-42-0
Product Code
AC-013
Category
Anti Cancer
Quality
WHO-GMP
Applications
Oral · Injection

Full description

Topoisomerase II inhibitor in pharmaceutical grade (≥95% HPLC purity) for capsule and IV solution formulation manufacturing. Sourced for testicular cancer, small-cell lung cancer, and lymphoma treatment protocols.

CAS 98319-26-7 Product Code AC-005 WHO-GMP

Finasteride

Type II 5-alpha reductase inhibitor in pharmaceutical grade for tablet formulation manufacturing. Primarily sourced for benign prostatic hyperplasia and androgenetic alopecia product lines.

Oral
Anti Cancer API

Finasteride

CAS
98319-26-7
Product Code
AC-005
Category
Anti Cancer
Quality
WHO-GMP
Applications
Oral

Full description

Type II 5-alpha reductase inhibitor in pharmaceutical grade for tablet formulation manufacturing. Primarily sourced for benign prostatic hyperplasia and androgenetic alopecia product lines.

CAS 122111-03-9 Product Code AC-006 WHO-GMP

Gemcitabine HCl

Nucleoside analogue antimetabolite supplied as hydrochloride salt — EP grade — for lyophilised IV infusion formulation manufacturing. Sourced for pancreatic, lung, bladder, and breast cancer treatment protocols.

EP Injection
Anti Cancer API

Gemcitabine HCl

CAS
122111-03-9
Product Code
AC-006
Category
Anti Cancer
Specification
EP
Quality
WHO-GMP
Applications
Injection

Full description

Nucleoside analogue antimetabolite supplied as hydrochloride salt — EP grade — for lyophilised IV infusion formulation manufacturing. Sourced for pancreatic, lung, bladder, and breast cancer treatment protocols.

CAS 220127-57-1 (mesylate) Product Code AC-007 WHO-GMP

Imatinib Beta / Alpha Form

BCR-ABL tyrosine kinase inhibitor mesylate salt supplied in beta (thermodynamically stable) and alpha crystalline polymorphic forms for tablet formulation manufacturing. Sourced for CML, ALL, and GIST treatment protocols.

Oral
Anti Cancer API

Imatinib Beta / Alpha Form

CAS
220127-57-1 (mesylate)
Product Code
AC-007
Category
Anti Cancer
Quality
WHO-GMP
Applications
Oral

Full description

BCR-ABL tyrosine kinase inhibitor mesylate salt supplied in beta (thermodynamically stable) and alpha crystalline polymorphic forms for tablet formulation manufacturing. Sourced for CML, ALL, and GIST treatment protocols.

CAS 33069-62-4 Product Code AC-009 WHO-GMP

Paclitaxel

Taxane mitotic inhibitor in USP/EP grade for IV infusion and albumin-bound nanoparticle formulation manufacturing. Sourced for breast, ovarian, lung cancer, and Kaposi's sarcoma treatment protocols.

USP EP Injection
Anti Cancer API

Paclitaxel

CAS
33069-62-4
Product Code
AC-009
Category
Anti Cancer
Specification
USP / EP
Quality
WHO-GMP
Applications
Injection

Full description

Taxane mitotic inhibitor in USP/EP grade for IV infusion and albumin-bound nanoparticle formulation manufacturing. Sourced for breast, ovarian, lung cancer, and Kaposi's sarcoma treatment protocols.

CAS 150399-23-8 (disodium) Product Code AC-008 WHO-GMP

Pemetrexed

Antifolate agent supplied as disodium salt — the standard parenteral trading form — for lyophilised IV infusion formulation manufacturing. Sourced for non-small cell lung cancer and malignant pleural mesothelioma protocols.

Injection
Anti Cancer API

Pemetrexed

CAS
150399-23-8 (disodium)
Product Code
AC-008
Category
Anti Cancer
Quality
WHO-GMP
Applications
Injection

Full description

Antifolate agent supplied as disodium salt — the standard parenteral trading form — for lyophilised IV infusion formulation manufacturing. Sourced for non-small cell lung cancer and malignant pleural mesothelioma protocols.

CAS 54965-24-1 Product Code AC-011 WHO-GMP

Tamoxifen Citrate

Selective oestrogen receptor modulator in USP/EP/BP grade for tablet formulation manufacturing. Sourced for oestrogen receptor-positive breast cancer treatment and chemoprevention product lines.

USP EP BP Oral
Anti Cancer API

Tamoxifen Citrate

CAS
54965-24-1
Product Code
AC-011
Category
Anti Cancer
Specification
USP / EP / BP
Quality
WHO-GMP
Applications
Oral

Full description

Selective oestrogen receptor modulator in USP/EP/BP grade for tablet formulation manufacturing. Sourced for oestrogen receptor-positive breast cancer treatment and chemoprevention product lines.

CAS 85622-93-1 Product Code AC-010 WHO-GMP

Temozolomide

Oral alkylating agent in pharmaceutical grade for capsule formulation manufacturing. Sourced for glioblastoma, anaplastic astrocytoma, and melanoma brain metastases treatment protocols.

Oral
Anti Cancer API

Temozolomide

CAS
85622-93-1
Product Code
AC-010
Category
Anti Cancer
Quality
WHO-GMP
Applications
Oral

Full description

Oral alkylating agent in pharmaceutical grade for capsule formulation manufacturing. Sourced for glioblastoma, anaplastic astrocytoma, and melanoma brain metastases treatment protocols.

CAS 118072-93-8 Product Code AC-012 WHO-GMP

Zoledronic Acid

Imidazole bisphosphonate in pharmaceutical grade (anhydrous and monohydrate forms available) for IV solution formulation manufacturing. Sourced for cancer bone metastases and hypercalcemia of malignancy treatment protocols.

Injection
Anti Cancer API

Zoledronic Acid

CAS
118072-93-8
Product Code
AC-012
Category
Anti Cancer
Quality
WHO-GMP
Applications
Injection

Full description

Imidazole bisphosphonate in pharmaceutical grade (anhydrous and monohydrate forms available) for IV solution formulation manufacturing. Sourced for cancer bone metastases and hypercalcemia of malignancy treatment protocols.

WHO-GMP Certified Sources
Global Delivery
Regulatory Support
Consistent Quality
Secure Packaging / Custom Options

Your RFQ List